Published in Cancer Weekly, February 18th, 2003
N. Ochiai and colleagues at Kyoto Prefectural University of Medicine described the case of a 17-year-old boy with CML in blast crisis, who "received a non-T cell-depleted (TCD) HLA haplo-identical three-loci mismatched hematopoietic stem cell transplant (HSCT) from his mother."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.